SRS
Sponsors
Lyra Medical Ltd., The George Institute for Global Health, China, Betta Pharmaceuticals Co., Ltd., Juergen Debus, Oncology Institute of Southern Switzerland
Conditions
Anterior Vaginal Wall ProlapseBrain MetastasesBrain Metastases From Solid TumorsBrain Metastases, AdultCancer BrainCardiovascular DiseaseGlioblastomaNon-small Cell Lung Cancer
Phase 2
High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases
NCT02726568
Start: 2016-03-31End: 2022-12-31Target: 30Updated: 2019-02-19
Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma
Active, not recruitingNCT04225039
Start: 2020-06-23End: 2029-04-30Updated: 2025-08-15
SMART Trial: Cognitive Sparing Brain Radiotherapy for Multiple Brain Metastases
Not yet recruitingNCT07505979
Start: 2026-04-01End: 2031-04-01Target: 90Updated: 2026-04-01
Unknown Phase
Demonstrate the Safety and Preformance of the SRS Device for the Treatment of Pelvic Organ Prolapse
CompletedNCT02209337
Start: 2014-09-30End: 2018-03-31Updated: 2019-08-16
China Rural Health Initiative Follow up Study
CompletedNCT02368418
Start: 2014-09-30End: 2016-08-31Target: 9164Updated: 2017-02-27
Whole Brain Radiation Therapy Alone vs. Radiosurgery for SCLC Patients With 1-10 Brain Metastases
CompletedNCT03297788
Start: 2017-12-01End: 2023-12-01Updated: 2024-01-05
Hypofractionated Brain Radiationcavity
CompletedNCT03561896
Start: 2015-01-31End: 2024-06-18Updated: 2024-07-17
The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?
RecruitingNCT05378633
Start: 2022-02-24End: 2028-02-24Target: 190Updated: 2026-03-10